Last $1.40 USD
Change Today +0.03 / 2.19%
Volume 643.0K
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pablo Lapuerta M.D.

Chief Medical Officer and Executive Vice President of Clinical Development, Lexicon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

51$968,852
As of Fiscal Year 2013

Background*

Dr. Pablo Lapuerta, MD has been the Chief Medical Officer at Lexicon Pharmaceuticals, Inc. since March 2011 and its Executive Vice President of Clinical Development since February 2013. Dr. Lapuerta has over 11 years of experience in the pharmaceutical industry. Dr. Lapuerta served as Chief Medical Officer and Senior Vice President of Clinical Strategy of Cogentus Pharmaceuticals Inc. He served as Senior Vice President of Clinical Development at Lexicon Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

8800 Technology Forest Place
The Woodlands, Texas 77381

United States

Phone: 281-863-3000
Fax: 281-863-8088

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Harvard College
MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

Salary$370,000
Total Annual Compensation$370,000

Stock Options*

Restricted Stock Awards$146,300
All Other Compensation$6,904
Exercisable Options232,875
Exercisable Options Value$11,002
Unexercisable Options455,125
Unexercisable Options Value$4,998
Total Value of Options$16,000
Total Number of Options688,000

Total Compensation*

Total Annual Cash Compensation$376,904
Total Short Term Compensation$370,000
Other Long Term Compensation$153,204
Total Calculated Compensation$968,852
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $1.40 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic, Inc.
$1.5M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
$900.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.